Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the China National Medical Products Administration (NMPA) has approved...
Accord Healthcare Announces Launch of Denosumab∇ – Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia® (Amgen), and Jubereq (denosumab), a biosimilar to Xgeva® (Amgen), following the scheduled expiry of the reference medicine's...
ZAGENO Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the life sciences e-commerce ecosystem. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that ZAGENO has been recognized with the 2025 Global Company of the Year Recognition in the life sciences e-commerce industry for its outstanding achievements in digital innovation,...
Amaran Biotech’s Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement
HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine adjuvant AB-801 has received an Acknowledgement Letter from the U.S. Food and Drug Administration (FDA) for its Type II Drug Master File (DMF). Amaran Biotech is now the first adjuvant supplier in Taiwan to obtain...
GC Biopharma’s Varicella Vaccine Strain ‘MAV/06’ Listed in WHO Position Paper
Officially recognized by WHO as a standard varicella vaccine strain alongside Oka Interchangeability endorsed, enhancing global supply security YONGIN, South Korea, Dec. 2, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceutical company, today announced that its proprietary varicella vaccine strain MAV/06 has been included in the World Health Organization (WHO) Position Paper...
Chula’s Deep GI: AI Revolutionizes Gastrointestinal Cancers Detection
BANGKOK, Dec. 2, 2025 /PRNewswire/ -- The Faculty of Medicine, Chulalongkorn University, in collaboration with the Faculty of Engineering, has developed "Deep GI," an artificial intelligence (AI) innovation designed to assist doctors in detecting gastrointestinal cancers with high standard performance equal to that of expert specialists. Trained on hundreds of thousands of endoscopic images, the system has received the...
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies for immune and inflammatory diseases, today announced that its innovative TYK2 allosteric inhibitor, LNK01006, has been approved by U.S. Food and Drug Administration (FDA) for human...
Suchang Accelerates Global Expansion With Dog Food Made From Jeju Citrus By-products
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Suchang a Korean manufacturer specializing in over 150 types of natural bio-based ingredients and overseas distribution consulting, announced that it has successfully developed a new dog food product using gamgyul-bak—by-products from Jeju's citrus processing industry. Tentatively branded as "Orange Dogs," the new product is designed for global markets, with export plans...
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence
LYON, France, Dec. 2, 2025 /PRNewswire/ -- NEJM Evidence, a journal of the New England Journal of Medicine Group, has published an article titled "Validation of a Saliva microRNA Signature for Endometriosis," dedicated to the saliva-based diagnostic test developed by Ziwig. The publication reports the results of a prospective, independent, multicenter clinical study...
Building Families with Innovation: Patient-First Vision Goes Digital
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) was delighted to welcome Westmead Fertility Centre to the agency fold for a wide-reaching digital transformation initiative. The engagement began with a comprehensive audit of Westmead Fertility Centre's digital infrastructure to identify opportunities across systems, tools, and platforms to deliver a truly patient-focused experience. This discovery phase included detailed...
